Selective Formation of ErbB-2/ErbB-3 Heterodimers Depends on the ErbB-3 Affinity of Epidermal Growth Factor-like Ligands*
Selective Formation of ErbB-2/ErbB-3 Heterodimers Depends on the ErbB-3 Affinity of Epidermal Growth Factor-like Ligands*
复制标题
ErbB-2/ErbB-3 异二聚体的选择性形成取决于表皮生长因子样配体的 ErbB-3 亲和力*
DOI:
--
复制
发表时间:
2003
影响因子:
4.8
通讯作者:
E. J. V. van Zoelen
中科院分区:
文献类型:
--
作者:
C. Stortelers;S. P. van der Woning;Saskia Jacobs;M. Wingens;E. J. V. van Zoelen
EGF-like growth factors activate their ErbB receptors by promoting receptor-mediated homodimerization or, alternatively, by the formation of heterodimers with the orphan ErbB-2 through an as yet unknown mechanism. To investigate the selectivity in dimer formation by ligands, we have applied the phage display approach to obtain ligands with modified C-terminal residues that discriminate between ErbB-2 and ErbB-3 as dimerization partners. We used the epidermal growth factor/transforming growth factor α chimera T1E as the template molecule because it binds to ErbB-3 homodimers with low affinity and to ErbB-2/ErbB-3 heterodimers with high affinity. Many phage variants were selected with enhanced binding affinity for ErbB-3 homodimers, indicating that C-terminal residues contribute to the interaction with ErbB-3. These variants were also potent ligands for ErbB-2/ErbB-3 heterodimers despite negative selection for such heterodimers. In contrast, phage variants positively selected for binding to ErbB-2/ErbB-3 heterodimers but negatively selected for binding to ErbB-3 homodimers can be considered as “second best” ErbB-3 binders, which require ErbB-2 heterodimerization for stable complex formation. Our findings imply that epidermal growth factor-like ligands bind ErbB-3 through a multi-domain interaction involving at least both linear endings of the ligand. Apparently the ErbB-3 affinity of a ligand determines whether it can form only ErbB-2/ErbB-3 complexes or also ErbB-3 homodimers. Because no separate binding domain for ErbB-2 could be identified, our data support a model in which ErbB heterodimerization occurs through a receptor-mediated mechanism and not through bivalent ligands.
DOI:
10.1073/pnas.91.17.8132
发表时间:
1994-08-16
影响因子:
11.1
作者:
GUY, PM;PLATKO, JV;CARRAWAY, KL
通讯作者:
CARRAWAY, KL
DOI:
10.1073/pnas.89.16.7801
发表时间:
1992
影响因子:
11.1
作者:
Woltjer,RL;Lukas,TJ;Staros,JV
通讯作者:
Staros,JV